3Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss [ J ]. Eur J Dermatol, 2004, 14 (6) :364-370.
4Tosti A,Iorizzo M, Botta GL,et al. Efficacy and safety of a new elobetasol propionate 0.05% foam in alopecia areata: a random- ized, double-blind placebo-controlled trial [ J]. J Eur Aead Dermatol Venereol,2006, 20(10) : 1243-1247.
5Tosti A, Piraceini BM, Pazzaglia M, et al. Clobetasol propionate 0.05% under occlu- sion in the treatment of alopecia totalis/ universalis [ J ]. J Am Acad Dermatol, 2003,49 ( 1 ) :96-98.
6Charuwichitratana S, Wattanakrai P, Tanrat- tanakorn S. Randomized double-blind pla- cebo-controlled trial in the treatment of alo- pecia areata with 0. 25% desoximetasone cream [ J ]. Arch Dermatol, 2000, 136 (10) : 1276-1277.
7Wang E, Lee JS, Tang M. Current treatment strategies in pediatric alopecia areata [ J ]. Indian J Dermato1,2012,57 (6) :459-465.
8Messenger AG, Mckillop J, Farrant P, et al. British Association of Dermatologists ' guidelines for the management of alopecia areata 2012 [ J ]. Br J Dermatol, 2012,166 (5) :916-926.
9Han JH, Kwon OS, Churlg JH, et al. Effect of minoxidik on proliferation and apoptosis in dermal papilla cells of human hair follicle [J]. J Dermatol Sci,2004,34(2) :91-98.
10Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata[ J]. Arch Dermatol, 1992, 128 ( 11 ): 1467-1473.
